knowt logo

W4 L11: Non-coding RNAs 

Non-coding RNA = doesn’t code for proteins

1st non-coding RNA

  • Alanine tRNA in baker’s yeast

  • Cloverleaf structure was solved in 1974

tRNA-Phe

  • tRNA decode the mRNA sequence during protein synthesis at ribosome

Ribosomal RNA

  • 80% of total RNA

  • Transcribed by Pol I (except 5S by Pol III)

  • Humans: 300-400 rDNA repeats on diff. chromosomes (13-15, 21, 22)

  • Eukaryotic ribosomes (2 subunits)

    • 40S subunit > 18S rRNA

    • 60S subunit > 5S, 5.8S, 28S

  • 5.8S, 18S & 28S are made from a single transcript (45S precursor) > rRNA processing in nucleolus

Total RNA isolated from human cells

  • 28s is biggest, 5.8s is smallest

Small nuclear RNAs - snRNAs

  • U-rich sequence involved in splicing (U1, U2, U4, U5, U6)

  • Base-pairing w/ pre-mRNAs defines splice-sites

  • From 107- 210 nts long, each associated w/ 6-10 proteins

    • small nuclear ribonucleoprotein particles (snRNPs)

  • Highly expressed (1 mio snRNPs) & evolutionarily conserved

Small nucleolar RNAs - snoRNAs

  • 200 diff species in mammals, 60-150 nts length

  • Most snoRNAs are encoded w/in introns of Pol II transcribed genes

  • Assemble w/ proteins to form small nucleolar ribonucleoproteins (snoRNPs)

  • Guide specific RNA modifications in i.e. rRNA by base-pairing

    • C/D box > directs 2’-O-ribose methylation by recruiting methyl transferase enzyme

    • H/ACA box > recruits an enzyme that converts uridine to pseudouridine

  • Main function takes place in nucleolus (>rRNA processing)

  • In C/D box → hybridise/ anneal w/ complementary seq. in rRNA → guide methylation of bases in rRNA

  • In H/ACA box → modify uridine base & form pseudouridine

miRNAs & siRNAs

  • Small non-coding RNAs affect translation or decay of mRNAs in cytoplasm

  • 20-22 nucleotides long RNA molecules

  • Specifically bind to complementary sequences locates in 3’-UTR regions of mRNAs (in complex w/ RNA-binding proteins (i.e. Ago)

  • Repress mRNA expression by promoting decay &/or inhibit translation

    • miRNAs → promoting deadenylation, translation, repression, decay

    • siRNA → cleavage of mRNA & exosome-mediated degradation

MicroRNAs repress translation by ‘imperfect’ hybridisation w/ target mRNAs in cytoplasm

siRNAs cleave mRNAs upon ‘perfect’ hybridisation

  • Established as defence mechanism against invading dsRNA viruses & unwanted actions of transposons/repetitive elements expressed from genome

  • “invading” dsRNA processed into siRNA that targets invader mRNAs for degradation

  • siRNA mediated defence mechanism are crucial in plants, worms & insects - less in mammals where a protein based system to fight viruses has taken over

How are miRNAs/siRNAs generated in cells?

Developmental defects in inducible 𝘋𝘪𝘤𝘦𝘳 gene knock-out

  • ‘Stable’ 𝘋𝘪𝘤𝘦𝘳 gene knock-out eliminates generation of miRNA in mammals & is embryonic lethal

  • ‘Conditional’ 𝘋𝘪𝘤𝘦𝘳 knock-out in limb primordia leads to defects in tissue morphogenesis/ development

miRNA & disease

  • ~5,000 diff miRNA regulate expression of almost every gene (>80%)

  • miRNA combinatorial control genes w/ crucial functions in cell proliferation, development, inflammation, ageing

  • Many miRNAs have been linked to disease (e.g. cancer oncogenes or tumour suppressor)

    • 1,100 miRNAa linked to more than 850 diseases

  • Represents a novel target for diagnostics (biomarkers) & drug development

    • discovery of extracellular miRNAs detectable in blood

miRNAs expression signatures classify human cancers

  • Profiling of miRNA expression in diff issues (tumours) enables to establish disease (tumour) specific ‘cancer markers’ for diagnostics

  • Many cancer-related miRNAs specifically target mRNAs coding for proteins w/ key functions in cell proliferation, migration & immune-response

    Heat-map representing expression of miRNAs in 6 solid tumours - expression signature

Long non-coding RNAs (lncRNAs)

  • Human: 16,000 lncRNA genes annotated (GENCODE v26) - giving raise to ~30,000 diff transcripts

  • Mainly transcribed by Pol II & sharing similarities w/ mRNAs → most lncRNAs contain a 5’ cap & a poly(A) tail at 3’end

  • Not translated into proteins but functional mols

  • Tissue/cell type specific expression - many of them v. low abundance (1-2 copies/cell)

  • Involved in many cellular processes e.g. gene imprinting, cell differentiation & development, antiviral response etc.

  • Function of thousands of incRNAs is unknown

LncRNAs can interact w/ proteins, RNA & DNA to execute regulatory functions in nucleus & cytoplasm

Nuclear lncRNAs control chromatin structure/transcription in cis or trans

XIST - 1st lncRNA discovered controls mammalian dosage compensation

XIST: X inactivation specific transcript

  • Xist is a large (17kb) cis-acting regulatory lncRNA

  • XIST associates w/ X-chromosome that is was expressed from (cis regulation)

  • Initiates histone modifications (methylation, deacetylation) →results in heterochromatin formation

  • Deletion of Xist gene abolishes X inactivation

    • Xa: active X chromosome

    • Xi: inactivated X chromosome

Cytoplasmic lncRNA have diverse functions

LncRNAs can regulate mRNA stability & translation (examples)

mRNA stability

  • lncRNA 𝘛𝘐𝘕𝘊𝘙 interacts w/ complementary sequences in a target mRNA & recruits RNA-binding protein (STAU1) → promotes stability of mRNA

Translational control

  • Under stress conditions, lncRNA antisense to Uchl1 moves from nucleus to cytoplasm & binds the end of Uchl1 mRNA to promote cap-independant translation

lncRNAs (NORAD) can act as decoy for RNA-binding proteins

  • NORAD is lncRNAs activated by DNA damage

  • NORAD IS ~5,3 kb polyadenylated transcript predominantly localised in cytoplasm

  • NORAD sequesters PUMILO RNA-binding proteins - acting as -ve regulator by limiting their availability to interact w/ mRNA targets

  • Involved in control of cell mitosis

Circular RNAs (circRNAs) can act as decoys for miRNAs/RBPs

  • 100s of circular RNAs (e.g. CDR1as) have recently been discovered in eukaryotes

  • CDRs are generated via back-splicing mechanisms by joining 5’ & 3’ end of linear RNA molecules originating from protein coding genes

  • CircRNAs lack cap/poly(A) tails - highly abundant & stable

  • Originally thought to be non-coding, but recent data shows circRNAs can be translated into proteins ( not really non-coding RNA)

SUMMARY

  • tRNAs and rRNAs are most abundant ncRNAs w/ fundamental functions in protein synthesis & ribosome architecture, respectively.

  • Small nuclear (snRNAs) are required for splicing

  • Small nucleolar RNAs (snoRNAs) guide site-specific modification of rRNA

  • Regulatory small ncRNAs such as miRNAs/siRNAs control gene expression post-transcriptionally by annealing to sequences in the 3’UTRs of mRNA targets.

  • Processing of miRNAs/siRNAs involves Drosha, Dicer & other proteins to finally form the RISC complex that assembles on mRNA target.

  • 1000s of lncRNAs (>200 nts) exist in eukaryotes that have nuclear & cytoplasmic functions in gene expression control.

  • Circular RNAs (circRNAs) are highly abundant & stable; produced by a back-splicing mechanism in eukaryotes.

W4 L11: Non-coding RNAs 

Non-coding RNA = doesn’t code for proteins

1st non-coding RNA

  • Alanine tRNA in baker’s yeast

  • Cloverleaf structure was solved in 1974

tRNA-Phe

  • tRNA decode the mRNA sequence during protein synthesis at ribosome

Ribosomal RNA

  • 80% of total RNA

  • Transcribed by Pol I (except 5S by Pol III)

  • Humans: 300-400 rDNA repeats on diff. chromosomes (13-15, 21, 22)

  • Eukaryotic ribosomes (2 subunits)

    • 40S subunit > 18S rRNA

    • 60S subunit > 5S, 5.8S, 28S

  • 5.8S, 18S & 28S are made from a single transcript (45S precursor) > rRNA processing in nucleolus

Total RNA isolated from human cells

  • 28s is biggest, 5.8s is smallest

Small nuclear RNAs - snRNAs

  • U-rich sequence involved in splicing (U1, U2, U4, U5, U6)

  • Base-pairing w/ pre-mRNAs defines splice-sites

  • From 107- 210 nts long, each associated w/ 6-10 proteins

    • small nuclear ribonucleoprotein particles (snRNPs)

  • Highly expressed (1 mio snRNPs) & evolutionarily conserved

Small nucleolar RNAs - snoRNAs

  • 200 diff species in mammals, 60-150 nts length

  • Most snoRNAs are encoded w/in introns of Pol II transcribed genes

  • Assemble w/ proteins to form small nucleolar ribonucleoproteins (snoRNPs)

  • Guide specific RNA modifications in i.e. rRNA by base-pairing

    • C/D box > directs 2’-O-ribose methylation by recruiting methyl transferase enzyme

    • H/ACA box > recruits an enzyme that converts uridine to pseudouridine

  • Main function takes place in nucleolus (>rRNA processing)

  • In C/D box → hybridise/ anneal w/ complementary seq. in rRNA → guide methylation of bases in rRNA

  • In H/ACA box → modify uridine base & form pseudouridine

miRNAs & siRNAs

  • Small non-coding RNAs affect translation or decay of mRNAs in cytoplasm

  • 20-22 nucleotides long RNA molecules

  • Specifically bind to complementary sequences locates in 3’-UTR regions of mRNAs (in complex w/ RNA-binding proteins (i.e. Ago)

  • Repress mRNA expression by promoting decay &/or inhibit translation

    • miRNAs → promoting deadenylation, translation, repression, decay

    • siRNA → cleavage of mRNA & exosome-mediated degradation

MicroRNAs repress translation by ‘imperfect’ hybridisation w/ target mRNAs in cytoplasm

siRNAs cleave mRNAs upon ‘perfect’ hybridisation

  • Established as defence mechanism against invading dsRNA viruses & unwanted actions of transposons/repetitive elements expressed from genome

  • “invading” dsRNA processed into siRNA that targets invader mRNAs for degradation

  • siRNA mediated defence mechanism are crucial in plants, worms & insects - less in mammals where a protein based system to fight viruses has taken over

How are miRNAs/siRNAs generated in cells?

Developmental defects in inducible 𝘋𝘪𝘤𝘦𝘳 gene knock-out

  • ‘Stable’ 𝘋𝘪𝘤𝘦𝘳 gene knock-out eliminates generation of miRNA in mammals & is embryonic lethal

  • ‘Conditional’ 𝘋𝘪𝘤𝘦𝘳 knock-out in limb primordia leads to defects in tissue morphogenesis/ development

miRNA & disease

  • ~5,000 diff miRNA regulate expression of almost every gene (>80%)

  • miRNA combinatorial control genes w/ crucial functions in cell proliferation, development, inflammation, ageing

  • Many miRNAs have been linked to disease (e.g. cancer oncogenes or tumour suppressor)

    • 1,100 miRNAa linked to more than 850 diseases

  • Represents a novel target for diagnostics (biomarkers) & drug development

    • discovery of extracellular miRNAs detectable in blood

miRNAs expression signatures classify human cancers

  • Profiling of miRNA expression in diff issues (tumours) enables to establish disease (tumour) specific ‘cancer markers’ for diagnostics

  • Many cancer-related miRNAs specifically target mRNAs coding for proteins w/ key functions in cell proliferation, migration & immune-response

    Heat-map representing expression of miRNAs in 6 solid tumours - expression signature

Long non-coding RNAs (lncRNAs)

  • Human: 16,000 lncRNA genes annotated (GENCODE v26) - giving raise to ~30,000 diff transcripts

  • Mainly transcribed by Pol II & sharing similarities w/ mRNAs → most lncRNAs contain a 5’ cap & a poly(A) tail at 3’end

  • Not translated into proteins but functional mols

  • Tissue/cell type specific expression - many of them v. low abundance (1-2 copies/cell)

  • Involved in many cellular processes e.g. gene imprinting, cell differentiation & development, antiviral response etc.

  • Function of thousands of incRNAs is unknown

LncRNAs can interact w/ proteins, RNA & DNA to execute regulatory functions in nucleus & cytoplasm

Nuclear lncRNAs control chromatin structure/transcription in cis or trans

XIST - 1st lncRNA discovered controls mammalian dosage compensation

XIST: X inactivation specific transcript

  • Xist is a large (17kb) cis-acting regulatory lncRNA

  • XIST associates w/ X-chromosome that is was expressed from (cis regulation)

  • Initiates histone modifications (methylation, deacetylation) →results in heterochromatin formation

  • Deletion of Xist gene abolishes X inactivation

    • Xa: active X chromosome

    • Xi: inactivated X chromosome

Cytoplasmic lncRNA have diverse functions

LncRNAs can regulate mRNA stability & translation (examples)

mRNA stability

  • lncRNA 𝘛𝘐𝘕𝘊𝘙 interacts w/ complementary sequences in a target mRNA & recruits RNA-binding protein (STAU1) → promotes stability of mRNA

Translational control

  • Under stress conditions, lncRNA antisense to Uchl1 moves from nucleus to cytoplasm & binds the end of Uchl1 mRNA to promote cap-independant translation

lncRNAs (NORAD) can act as decoy for RNA-binding proteins

  • NORAD is lncRNAs activated by DNA damage

  • NORAD IS ~5,3 kb polyadenylated transcript predominantly localised in cytoplasm

  • NORAD sequesters PUMILO RNA-binding proteins - acting as -ve regulator by limiting their availability to interact w/ mRNA targets

  • Involved in control of cell mitosis

Circular RNAs (circRNAs) can act as decoys for miRNAs/RBPs

  • 100s of circular RNAs (e.g. CDR1as) have recently been discovered in eukaryotes

  • CDRs are generated via back-splicing mechanisms by joining 5’ & 3’ end of linear RNA molecules originating from protein coding genes

  • CircRNAs lack cap/poly(A) tails - highly abundant & stable

  • Originally thought to be non-coding, but recent data shows circRNAs can be translated into proteins ( not really non-coding RNA)

SUMMARY

  • tRNAs and rRNAs are most abundant ncRNAs w/ fundamental functions in protein synthesis & ribosome architecture, respectively.

  • Small nuclear (snRNAs) are required for splicing

  • Small nucleolar RNAs (snoRNAs) guide site-specific modification of rRNA

  • Regulatory small ncRNAs such as miRNAs/siRNAs control gene expression post-transcriptionally by annealing to sequences in the 3’UTRs of mRNA targets.

  • Processing of miRNAs/siRNAs involves Drosha, Dicer & other proteins to finally form the RISC complex that assembles on mRNA target.

  • 1000s of lncRNAs (>200 nts) exist in eukaryotes that have nuclear & cytoplasmic functions in gene expression control.

  • Circular RNAs (circRNAs) are highly abundant & stable; produced by a back-splicing mechanism in eukaryotes.

robot